Accelerating research intelligence with AI: an interview with Daniel Jamieson, CEO and Founder of Biorelate | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Accelerating research intelligence with AI: an interview with Daniel Jamieson, CEO and Founder of Biorelate

Publication year - 2020

Publication title -

the biochemist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.126

H-Index - 7

eISSN - 1740-1194

pISSN - 0954-982X

DOI - 10.1042/bio20200049

Subject(s) - biochemist , management , repurposing , vice president , library science , sociology , engineering , history , computer science , classics , economics , waste management

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insights and innovation in future drug discovery. Daniel started Biorelate in the midst of a computational biology PhD at the University of Manchester after the successful identification of drug repurposing opportunities with Pfizer. He is now coming up to 7 years into that journey, and his focus remains on turning Biorelate into a world-leading enterprise, helping pioneering companies and researchers in their mission to develop life-saving innovations. The Biochemist spoke to Daniel about the journey so far.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research